HFMA Comments on CY 2026 Hospital OPPS and ASC Proposed Rule
HFMA submits comments to CMS pertaining to CMS-1834-P CY 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center Proposed Rule.
HFMA Comments on Revisions to Payment Policies under the CY 2026 Medicare PFS, Quality Payment Program and Other Revisions to Part B
HFMA submits comments pertaining to Proposed Rule CMS-1832-P Revisions to Payment Policies under the Medicare Physician Fee Schedule, Quality Payment Program and Other Revisions to Part B for CY 2026.
HFMA Comments on CMS Hospital Price Transparency Accuracy and Completeness RFI
HFMA submits recommendations pertaining to CMS Hospital Price Transparency Accuracy and Completeness Request for Information.
HFMA Submits Closing Recommendations to Mitigate Effects and Unintended Consequences of Largest Reform to Federal Medicaid in Program History
HFMA submits closing recommendations to mitigate certain effects and unintended consequences of the largest reform to federal Medicaid in program history to Senate Leader Thune and House Speaker Johnson.
HFMA Comments on Unleashing Prosperity Through Deregulation of the Medicare Program (Executive Order 14192) RFI
HFMA submits recommendations pertaining to the Unleashing Prosperity Through Deregulation of the Medicare Program (Executive Order 14192) - Request for Information.
HFMA Comments on Federal Independent Dispute Resolution Operations, Proposed Rule
HFMA presents its comment letter on CMS’ Federal Independent Dispute Resolution Operations Proposed Rule.
HFMA Comments on Federal Independent Dispute Resolution Process Fees Proposed Rule
HFMA presents its comment letter on CMS’ Federal Independent Dispute Resolution Process Fees Proposed Rule.
HFMA Comments on Request for Information Regarding Medical Payment Products
HFMA presents its comment letter to CMS on Request for Information Regarding Medical Payment Products
HFMA Comments on Hospital OPPS: Proposed Remedy for the 340B-Acquired Drug Payment Policy for CYs 2018–2022
HFMA presents its comment letter to CMS on the proposed rule, Medicare Program; Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018–2022.